Variational AI, through its Enki™ platform, leverages generative AI to create novel and diverse drug-like small molecules. This cutting-edge technology allows for rapid optimization of multiple properties necessary to produce effective drugs, thereby speeding up the drug discovery process. Variational AI aims to redefine the economics of drug development, minimizing time and costs while maximizing the potential for discovering life-saving treatments. Collaborating closely with biopharmaceutical companies, they are pioneering a new era in drug discovery.